Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 231-240 of 411 for multiple

Edit search filters
  1. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, And Dexamethasone To Pomalidomide And Dexamethasone In Refractory Or Relapsed And Refractory Multiple Myeloma Patients

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study Comparing JNJ-79635322 And An Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody In Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Effectiveness Of AMG 397 In Subjects With Multiple Myeloma, NHL, And AML

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Study To Investigate The Safety And Effectiveness Of Two Doses Of The Antibody Drug GSK2857916 In Relapsed/Refractory Multiple Myeloma Patients

    Rochester, MN

  5. Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia

    Rochester, MN

  6. Phase II Study Of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed By Maintenance Ixazomib Or Lenalidomide For Multiple Myeloma

    Rochester, MN

  7. A Phase 1 Dose-escalation And Expansion Study Of In Vivo BCMA-CAR T Cell Therapy (VV169) In Patients With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Study Of ABBV-383 Assessing Adverse Events And Clinical Activity With Subcutaneous (SC) Injection In Adult Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study To Investigate The Safety And Tolerability Of Single And Multiple Ascending Doses Of Antisense Oligonucleotide STK-001 In Children And Adolescents With Dravet Syndrome

    Rochester, MN

  10. Safety And Tolerability Study Of SNS01-T In Relapsed Or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, Or Plasma Cell Leukemia (PCL)

    Rochester, MN

.

Mayo Clinic Footer